Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gleave

Showing results (601-610 of 839) with videos related to

Pageof 84
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2016
<i>BIRC6</i> Targeting as Potential Therapy for Advanced, Enzalutamide-Resistant Prostate CancerIris Sze Ue Luk, Raunak Shrestha, Hui Xue, et al.
The Prostate|September 8, 2007
Regulation of global gene expression in the bone marrow microenvironment by androgen: androgen ablation increases insulin-like growth factor binding protein-5 expressionChang Xu, Lynn F Graf, Ladan Fazli, et al.
Scientific Reports|March 26, 2024
Clinically-observed FOXA1 mutations upregulate SEMA3C through transcriptional derepression in prostate cancerKevin J Tam, Liangliang Liu, Michael Hsing, et al.
Sexually Transmitted Infections|February 11, 2003
Opportunistic screening for genital chlamydial infection. I: acceptability of urine testing in primary and secondary healthcare settingsJ M Pimenta, M Catchpole, P A Rogers, et al.
BMC Palliative Care|January 28, 2019
"Just too busy living in the moment and surviving": barriers to accessing health care for structurally vulnerable populations at end-of-lifeK I Stajduhar, A Mollison, M Giesbrecht, et al.
Plos One|August 11, 2012
Identification of CD166 as a surface marker for enriching prostate stem/progenitor and cancer initiating cellsJing Jiao, Antreas Hindoyan, Shunyou Wang, et al.
Molecular Cancer Research : MCR|January 8, 2025
Exploring B7-H4's Role in Prostate Cancer Dormancy after Androgen Deprivation Therapy: Extracellular Matrix Interactions and Therapeutic OpportunitiesNing Kang, Hui Xue, Nelson K Y Wong, et al.
Sexually Transmitted Infections|February 11, 2003
Opportunistic screening for genital chlamydial infection. II: prevalence among healthcare attenders, outcome, and evaluation of positive casesJ M Pimenta, M Catchpole, P A Rogers, et al.
Cancer Medicine|June 16, 2018
Targeting MCT4 to reduce lactic acid secretion and glycolysis for treatment of neuroendocrine prostate cancerStephen Yiu Chuen Choi, Susan L Ettinger, Dong Lin, et al.
Journal of the National Cancer Institute|September 21, 2013
Targeting amino acid transport in metastatic castration-resistant prostate cancer: effects on cell cycle, cell growth, and tumor developmentQian Wang, Jessamy Tiffen, Charles G Bailey, et al.
Pageof 84

Showing results (601-610 of 839) with videos related to

Sort By:
Pageof 84
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2016
<i>BIRC6</i> Targeting as Potential Therapy for Advanced, Enzalutamide-Resistant Prostate CancerIris Sze Ue Luk, Raunak Shrestha, Hui Xue, et al.
The Prostate|September 8, 2007
Regulation of global gene expression in the bone marrow microenvironment by androgen: androgen ablation increases insulin-like growth factor binding protein-5 expressionChang Xu, Lynn F Graf, Ladan Fazli, et al.
Scientific Reports|March 26, 2024
Clinically-observed FOXA1 mutations upregulate SEMA3C through transcriptional derepression in prostate cancerKevin J Tam, Liangliang Liu, Michael Hsing, et al.
Sexually Transmitted Infections|February 11, 2003
Opportunistic screening for genital chlamydial infection. I: acceptability of urine testing in primary and secondary healthcare settingsJ M Pimenta, M Catchpole, P A Rogers, et al.
BMC Palliative Care|January 28, 2019
"Just too busy living in the moment and surviving": barriers to accessing health care for structurally vulnerable populations at end-of-lifeK I Stajduhar, A Mollison, M Giesbrecht, et al.
Plos One|August 11, 2012
Identification of CD166 as a surface marker for enriching prostate stem/progenitor and cancer initiating cellsJing Jiao, Antreas Hindoyan, Shunyou Wang, et al.
Molecular Cancer Research : MCR|January 8, 2025
Exploring B7-H4's Role in Prostate Cancer Dormancy after Androgen Deprivation Therapy: Extracellular Matrix Interactions and Therapeutic OpportunitiesNing Kang, Hui Xue, Nelson K Y Wong, et al.
Sexually Transmitted Infections|February 11, 2003
Opportunistic screening for genital chlamydial infection. II: prevalence among healthcare attenders, outcome, and evaluation of positive casesJ M Pimenta, M Catchpole, P A Rogers, et al.
Cancer Medicine|June 16, 2018
Targeting MCT4 to reduce lactic acid secretion and glycolysis for treatment of neuroendocrine prostate cancerStephen Yiu Chuen Choi, Susan L Ettinger, Dong Lin, et al.
Journal of the National Cancer Institute|September 21, 2013
Targeting amino acid transport in metastatic castration-resistant prostate cancer: effects on cell cycle, cell growth, and tumor developmentQian Wang, Jessamy Tiffen, Charles G Bailey, et al.
Pageof 84